A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Local Institution - 0017, Copenhagen

Local Institution - 0016, Copenhagen

Local Institution - 0015, Odense

Local Institution - 0008, Pittsburgh

Local Institution - 0027, Madrid

Local Institution - 0023, Madrid

Local Institution - 0026, Málaga

Local Institution - 0025, Pamplona

Local Institution - 0005, Sioux Falls

Local Institution - 0030, Fort Worth

Local Institution - 0020, San Antonio

Local Institution - 0031, Salt Lake City

Local Institution - 0002, Los Angeles

Local Institution - 0021, Orange

Local Institution - 0028, Seattle

Local Institution - 0029, Chuo-ku

Local Institution - 0022, Badalona

Local Institution - 0024, Barcelona